RFK's wellness movement highlights systemic over-reliance on mental-health pharmaceuticals in U.S. healthcare
Original framing: “Three mental-health claims from RFK’s wellness movement: what scientists say” — Nature
The over-prescription of mental health drugs in the U.S. has roots in the mid-20th century, when pharmaceutical companies began aggressively marketing psychotropic medications. This parallels the rise of the Diagnostic and Statistical Manual of Mental Disorders (DSM), which expanded diagnostic categories to include conditions with broad, subjective criteria.
The critique of over-prescription in mental health care must be understood within the broader context of a healthcare system shaped by pharmaceutical profits, insurance incentives, and cultural biases.
Indigenous and non-Western healing practices offer alternative frameworks that emphasize community and holistic well-being, which are often excluded from mainstream discourse. Historical patterns show how diagnostic criteria and pharmaceutical marketing have expanded the scope of mental illness, often at the expense of alternative care models. A systemic solution requires reforming financial incentives, integrating diverse healing modalities, and centering the voices of those most affected by mental health inequities. By doing so, we can move toward a more just and effective mental health system.